About MGI Pharma
MGI Pharma is a Healthcare company based in Woodcliff Lake (United States) founded in 1979, and was acquired by Eisai in December 2007. Oncology and acute care pharmaceuticals are developed and commercialized. MGI Pharma has completed 3 acquisitions, including Aesgen, Guildford Pharmaceuticals and Zycos. Its focus areas include Traditional Pharmaceuticals, Generics, Therapeutic Areas and Oncology.
Company details
The company was founded in 1979 in Woodcliff Lake, United States, and focused on the pharmaceutical sector, particularly oncology and acute care applications. Pharmaceutical products were developed and commercialized, including Aloxi injection, Dacogen for injection, and Gliadel Wafer. Operations were conducted under the name Molecular Genetics Inc. until 1990, when it became MGI Pharma. Acquisition by Eisai Holdings US subsidiary occurred in 2008.
- Headquarters Woodcliff Lake, United States
- Stage Acquired
- SectorsHealthcare
- Website mgipharma.com
- Acquired by Eisai (Dec 2007)
Investors in MGI Pharma
MGI Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Eisai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drugs for oncology and neurological disorders are developed by Eisai. | 1941 | eisai.com | Tokyo, Japan |
Investor details for MGI Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MGI Pharma
MGI Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aesgen, Guildford Pharmaceuticals and Zycos.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A US-based specialty pharmaceutical company developing small molecule therapeutics for cancer and neurology. | guilfordpharm.com | Woodcliff Lake, United States | 1996 | Jul 2005 | $177.5M | |
Limited information available | zycos.com | Minneapolis, United States | 1999 | Sep 2004 | $50M | |
Limited information available | aesgen.net | Princeton, United States | 1994 | Sep 2004 | $32M |
Complete acquisition details for MGI Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MGI Pharma
5 dated milestones of MGI Pharma across 28 years, from founding to its latest funding, stage changes and deals.
- Founded MGI Pharma is founded.
- Acquisition Acquires Aesgen.
- Acquisition Acquires Zycos.
- Acquisition Acquires Guildford Pharmaceuticals.
- Exit Acquired by Eisai.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as MGI Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MGI Pharma
MGI Pharma was founded in 1979.
MGI Pharma is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
The company was founded in 1979 in Woodcliff Lake, United States, and focused on the pharmaceutical sector, particularly oncology and acute care applications. Pharmaceutical products were developed and commercialized, including Aloxi injection, Dacogen for injection, and Gliadel Wafer. Operations were conducted under the name Molecular Genetics Inc. until 1990, when it became MGI Pharma. Acquisition by Eisai Holdings US subsidiary occurred in 2008.
MGI Pharma has made 3 acquisitions, including Aesgen, Guildford Pharmaceuticals, and Zycos.
MGI Pharma has 1 investor. Key investors include Eisai.
Yes. MGI Pharma was acquired by Eisai in December 2007.